← Eichor
Condition: Overweight With Diabetes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Overweight With Diabetes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and O
NA · 3 location(s) · University of Primorska · NCT07423065Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
NA · 1 location(s) · Kazakh Academy of Nutrition · NCT07728669Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
NA · 3 location(s) · Beijing Anzhen Hospital · NCT07372729Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study
NA · 1 location(s) · Nottingham University Hospitals NHS Trust · NCT06572345A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Phase 2/Phase 3 · 4 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07284511Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabete
Phase 3 · 116 location(s) · Kailera · NCT07284901Butyrate-enriched Triglyceride and Diabetes Prevention
NA · 1 location(s) · Maastricht University Medical Center · NCT06384313A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes
NA · 1 location(s) · Steno Diabetes Center Copenhagen · NCT07262788Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
Phase 1 · 4 location(s) · OrsoBio, Inc · NCT05822544Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semagluti
Phase N/A · 2 location(s) · Hospital Italiano de Buenos Aires · NCT07621419Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class
NA · 1 location(s) · University Hospital, Grenoble · NCT05516576A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or
Phase 3 · 321 location(s) · AstraZeneca · NCT07667803DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity
NA · 1 location(s) · Adhera Health, Inc. · NCT07638345A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · 163 location(s) · Hoffmann-La Roche · NCT07351058Effects of VLCKD in Metabolic Syndrome
NA · 1 location(s) · Azienda Ospedaliero Universitaria Maggiore della Carita · NCT05275608Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
Phase 3 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07279194Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabe
Phase 4 · 1 location(s) · Alexandra Kautzky-Willer · NCT03851627Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Rela
Phase 2 · 36 location(s) · Kailera · NCT07497880SnapDandCGMinType2Diabetes
NA · 1 location(s) · Ramathibodi Hospital · NCT07533604Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM
NA · 1 location(s) · Universiti Putra Malaysia · NCT06590519Exercise and Protein Efficiency in T2D
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07477067A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · 40 location(s) · Eli Lilly and Company · NCT07589608Tirzepatide Use in People With Obesity and Type 1 Diabetes
Phase 4 · 1 location(s) · Dasman Diabetes Institute · NCT07096908A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obe
Phase 3 · 303 location(s) · Novo Nordisk A/S · NCT07564414Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NA · 5 location(s) · Indiana University · NCT05124808Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · 53 location(s) · Kailera · NCT07284979A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabete
Phase 4 · 30 location(s) · Eli Lilly and Company · NCT07247084Growth Hormone Resistance of Beta-cells A
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT06571487Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded
NA · 1 location(s) · Azienda Ospedaliero-Universitaria Consorziale Policlinico di · NCT07185555A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze
Phase 2 · 60 location(s) · Eli Lilly and Company · NCT06897475
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.